BEDFORD, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday,...
1 Healthcare Stock to Target This Week and 2 We Ignore
3 Profitable Stocks We Think Twice About
3 Cash-Producing Stocks Walking a Fine Line
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
3 Russell 2000 Stocks We’re Skeptical Of
BEDFORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians...
3 Reasons to Sell LNTH and 1 Stock to Buy Instead
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines the diagnostic performance of PYLARIFY ® (piflufolastat F 18) with the potential for larger batches and greater...